H
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Henrique Rodrigues investigates mechanisms to enhance the effectiveness of cancer radiotherapy. His work has explored the role of specific signaling pathways, such as the RAS-RAF-miR-296-3p axis, in contributing to radioresistance in pancreatic and thyroid cancers by increasing Rad18 expression. Rodrigues has also studied strategies to improve radiosensitivity in rectal and pancreatic cancers through interventions like targeting SETD2 or inhibiting cyclin-dependent kinase 1. Further research has examined the impact of dietary modifications, specifically methionine restriction, on radiosensitizing KRAS mutant rectal cancer and protecting the gut microbiome. He has published 24 papers, with a total of 254 citations, and has an h-index of 5. Rodrigues collaborates with several researchers at the University of Arkansas for Medical Sciences, including Oscar Zuniga and Lokesh Akana, with whom he has co-authored four publications.
Metrics
- h-index: 5
- Publications: 26
- Citations: 254
Selected Publications
-
Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025)
-
SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models (2025)
-
Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025)
-
Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)
-
RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers (2024)
-
Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer (2024)
-
Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy (2023)
-
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)
Collaboration Network
Top Collaborators
Adam R. Wolfe
University of Arkansas for Medical Sciences (US)
6 shared publications
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Showing 5 of 6 shared publications
Oscar Zuniga
University of Arkansas for Medical Sciences
4 shared publications
In database
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Lokesh Akana
University of Arkansas for Medical Sciences
4 shared publications
In database
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
Saaimatul Huq
University of Arkansas for Medical Sciences (US)
3 shared publications
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
Sarita Garg
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Stetson Van Matre
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
Nükhet Aykin‐Burns
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Isabelle R. Miousse
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Robin Eluvathingal
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Haihua Feng
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Daniel E. Eldridge
Winthrop Rockefeller Foundation (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Linlin Yang
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Changxian Shen
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Terence M. Williams
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Óscar Zúñiga
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
Similar Researchers
Based on overlapping research topics
Lokesh Akana
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Radiation Therapy and Dosimetry
Cancer-related molecular mechanisms research
Robin Eluvathingal
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Radiation Therapy and Dosimetry
Cancer-related molecular mechanisms research
Oscar Zuniga
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Radiation Therapy and Dosimetry
Cancer-related molecular mechanisms research
Stetson Van Matre
University of Central Arkansas
Cancer Treatment and Pharmacology
Radiation Therapy and Dosimetry
Cancer-related molecular mechanisms research
Lee, Seongok
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Radiation Therapy and Dosimetry
Cancer-related molecular mechanisms research
Felicia D. Allard
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Diet and metabolism studies